US Stem Cell Inc (CE) (USRM)
USOTC
Year End December 30 2022 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 5.52M | 6.7M | 3.07M | 277k | 201k | 82k |
Operating Income | -612k | -850k | -3.42M | -2.4M | -2.14M | -1.72M |
Pre Tax Income | -3.48M | -2.16M | -3.84M | -2.89M | -3.29M | -2.86M |
Net Income | -3.48M | -2.16M | -3.84M | -2.89M | -3.29M | -2.86M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.01 | -0.006 | -0.009 | -0.007 | -0.007 | -0.005 |
EBIT | -948k | -715k | -2.97M | -2.38M | -2.29M | -1.72M |
EBITDA | -433k | -643k | -3.17M | -2.4M | -2.14M | -1.72M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.